CFRA's Garrett Nelson downgraded the company's stock to Sell...

CFRA's Garrett Nelson downgraded the company's stock to Sell, predicting a drop to $275 within a year. UBS's Peter Grom kept a Neutral rating but reduced his price target to $355 from $390, citing doubts about near-term sales growth.